COMMUNIQUÉS West-GlobeNewswire

Universe Pharmaceuticals INC Reports Financial Results for The First Six Months of Fiscal Year 2024
20/09/2024
JI’AN, Jiangxi, China, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company,” “we,” “our” and “us”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced its [...]
Sutro Biopharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
20/09/2024
SOUTH SAN FRANCISCO, Calif., Sept. 20, 2024 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and novel-format antibody-drug [...]
ONWARD® Medical Annonce la Cotation de ses Titres sur le Marché Euronext Paris
20/09/2024
La société a des racines françaises et des liens significatifs avec la France La société collabore étroitement avec le CEA-Clinatec, institut de recherche biomédicale de renommée mondiale financé par le gouvernement [...]
L’Arche Vancouver opens new $37-Million Dream Home
20/09/2024
BURNABY, British Columbia, Sept. 20, 2024 (GLOBE NEWSWIRE) -- L’Arche Greater Vancouver has fulfilled the biggest dream in its 50-year history today, by replacing its old building on the Sussex Avenue property in [...]
Wounded Warriors Family Support Provides Veterans with Program Toward Financial Competency, Independence
20/09/2024
OMAHA, Neb., Sept. 20, 2024 (GLOBE NEWSWIRE) -- According to a 2021 Military Family Support Programming Survey, 80.7% of respondents indicated that their finances caused them some stress over the past 12 months. The [...]
Zevra Therapeutics’ MIPLYFFA™ (arimoclomol) Receives U.S. FDA Approval as Treatment for Niemann-Pick Disease Type C
20/09/2024
MIPLYFFA is the first FDA-approved treatment for Niemann-Pick disease type C (NPC), an ultra-rare and progressive neurodegenerative disease MIPLYFFA is indicated for use in combination with miglustat for the treatment [...]
TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc.
20/09/2024
TAMPA, FL and COMMACK, NY, Sept. 20, 2024 (GLOBE NEWSWIRE) -- TRxADE Health, Inc. (“TRxADE”) (NASDAQ: MEDS) and Scienture, LLC (“Scienture”), a wholly owned subsidiary of TRxADE, today announced that it is changing its [...]
Onconetix, Inc. Announces 1-for-40 Reverse Stock Split and Results of the Annual Meeting of Stockholders
20/09/2024
CINCINNATI, Ohio, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Onconetix, Inc. (NASDAQ: ONCO) (“Onconetix” or the “Company”), a commercial-stage biotechnology company focused on the research, development, and commercialization of [...]
Psyence Group Enters into Agreement to Dispose of Stake in PsyLabs
20/09/2024
PsyLabs develops and produces certified pharmaceutical-grade natural psychedelics for applications in mental health and well-being NEW YORK, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Psyence Group Inc (" Psyence Group " or the [...]
ChemoMetec makes offer to buy Ovizio Imaging Systems SA
20/09/2024
ANNOUNCEMENT NO. 276 20 September 2024 ChemoMetec makes offer to buy Ovizio Imaging Systems SA ChemoMetec has submitted an indicative offer to buy Belgian company Ovizio Imaging Systems (‘Ovizio’), which has been [...]
Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons
20/09/2024
Please see enclosed pdf. Attachment 20092024_trading_in_shares_LRA
Range Impact Announces Application to Uplist to the OTCQB Venture Market
20/09/2024
CLEVELAND, OHIO, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTC: RNGE) (“Range Impact” or the “Company”), a public company dedicated to improving the health and wellness of people and the planet through a [...]
Supernus Pharmaceuticals to Participate in the TD Cowen 4th Annual Novel Mechanisms in Neuropsychiatry Summit
19/09/2024
ROCKVILLE, Md., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous [...]
ADR Ratio Change
19/09/2024
September 19, 2024 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) ADR Ratio Change Biodexa Pharmaceuticals PLC (Nasdaq: BDRX), an acquisition-focused clinical stage biopharmaceutical company developing a [...]
Zenas BioPharma Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares in Initial Public Offering
19/09/2024
WALTHAM, Mass., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization [...]
GENFIT Reports First Half-Year 2024 Financial Results and Provides Corporate Update
19/09/2024
Cash and cash equivalents totaled €61.6 million as of June 30, 2024, excluding the €48.7 million milestone invoiced in June 2024 (received in August 2024) upon first sale of Ipsen’s Iqirvo® (elafibranor) in the U.S. for [...]
GENFIT : Résultats financiers du premier semestre 2024 et point sur les activités de la Société
19/09/2024
Trésorerie et équivalents de trésorerie s’éle vant à 61,6 m illio ns d’euros au 30 juin 2024 n’incluant pas le paiement d’étape de 48,7 millions d’euros facturé en juin 2024 (reçu en août 2024) lors de la première vente [...]
Rezolute Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results and Provides Business Update
19/09/2024
FDA lifts partial clinical holds on ersodetug for the treatment of congenital HI; Phase 3 sunRIZE study to proceed in the U.S. Phase 3 study for ersodetug for the treatment of tumor HI expected to commence in the first [...]
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
19/09/2024
SAN FRANCISCO, Sept. 19, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative [...]

Pages